We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $3.89B
1-Year Est. Return 16.15%
This Fund
S&P 500
This Quarter Est. Return
-13.93%
1 Year Est. Return
+16.15%
3 Year Est. Return
+48.47%
5 Year Est. Return
+55.5%
10 Year Est. Return
+378.36%
AUM
$9.84B
AUM Growth
-$1.44B
Cap. Flow
+$331M
Cap. Flow %
3.36%
Top 10 Hldgs %
19.04%
Holding
125
New
7
Increased
65
Reduced
46
Closed
6

Sector Composition

Rank Sector Weight
1 Healthcare 22.08%
2 Technology 21.1%
3 Industrials 16.12%
4 Financials 14.2%
5 Consumer Staples 12.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MASI
51
DELISTED
Masimo
MASI
$85.8M 0.87%
798,650
+91,630
+13% +$10.2M
CFR icon
52
Cullen/Frost Bankers
CFR
$10.1B
$82.3M 0.84%
935,835
+8,280
+0.9% +$806K
TWNK
53
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$81.5M 0.83%
7,449,950
+1,092,140
+17% +$12M
BGS icon
54
B&G Foods
BGS
$257M
$80.8M 0.82%
2,795,815
-168,921
-6% -$4.83M
FUL icon
55
H.B. Fuller
FUL
$2.78B
$77.4M 0.79%
1,814,935
-21,440
-1% -$971K
GWRE icon
56
Guidewire Software
GWRE
$12.7B
$77.4M 0.79%
964,385
+84,785
+10% +$7.39M
WWD icon
57
Woodward
WWD
$19.9B
$77.4M 0.79%
1,041,230
-164,735
-14% -$12.7M
VVV icon
58
Valvoline
VVV
$3.9B
$76.9M 0.78%
3,974,570
+7,205
+0.2% +$144K
CSII
59
DELISTED
Cardiovascular Systems, Inc.
CSII
$73.8M 0.75%
2,590,880
+198,300
+8% +$6.3M
SNPS icon
60
Synopsys
SNPS
$73.1B
$73.8M 0.75%
875,682
+1,140
+0.1% +$101K
GTES icon
61
Gates Industrial Corp
GTES
$6.59B
$73.5M 0.75%
5,548,670
+213,355
+4% +$3.2M
JBTM
62
JBT Marel
JBTM
$5.93B
$71.9M 0.73%
1,001,710
+18,910
+2% +$1.68M
WBT
63
DELISTED
Welbilt, Inc.
WBT
$68.5M 0.7%
6,167,875
+201,590
+3% +$3.11M
BF.B icon
64
Brown-Forman Class B
BF.B
$12B
$68.3M 0.69%
+1,436,165
New +$68.2M
MSA icon
65
Mine Safety
MSA
$7.03B
$68.3M 0.69%
724,830
+41,930
+6% +$4.28M
CBSH icon
66
Commerce Bancshares
CBSH
$8.35B
$67.7M 0.69%
1,690,603
+26,648
+2% +$1.14M
QLYS icon
67
Qualys
QLYS
$5.2B
$67.7M 0.69%
906,025
-18,405
-2% -$1.39M
CMD
68
DELISTED
Cantel Medical Corporation
CMD
$64.5M 0.66%
865,820
+664,510
+330% +$54.9M
PBH icon
69
Prestige Consumer Healthcare
PBH
$2.22B
$63.1M 0.64%
2,043,965
-34,580
-2% -$1.26M
QTWO icon
70
Q2 Holdings
QTWO
$3.8B
$62.1M 0.63%
1,253,270
+413,300
+49% +$21.1M
CPB icon
71
Campbell Soup
CPB
$6.34B
$62M 0.63%
1,880,435
+1,670
+0.1% +$63.2K
NAVG
72
DELISTED
Navigators Group Inc
NAVG
$59.6M 0.61%
858,105
-425,050
-33% -$29.5M
WWW icon
73
Wolverine World Wide
WWW
$1.64B
$59.4M 0.6%
1,862,370
-87,545
-4% -$2.98M
INDB icon
74
Independent Bank
INDB
$3.92B
$59.3M 0.6%
842,950
+86,375
+11% +$6.7M
ANSS
75
DELISTED
Ansys
ANSS
$57M 0.58%
398,615
+13,265
+3% +$2.06M

Similar funds

Champlain Investment Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Champlain Investment Partners held 125 positions worth $9.84B, down 13% from $11.3B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Champlain Investment Partners deployed $331M of net new capital in Q4 2018, opening 7 new positions and adding to 65 existing holdings. Its largest new stake was Nutanix: 2,404,770 shares worth $100M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Hormel Foods, an estimated $90.6M trimmed.

  • Champlain Investment Partners's largest Q4 2018 buy was Nutanix: 2,404,770 shares worth $100M.
  • Champlain Investment Partners added most to New Relic, Inc. in Q4 2018, an estimated $57.8M increase.
  • Champlain Investment Partners's biggest Q4 2018 reduction was Hormel Foods, cutting an estimated $90.6M.
  • Champlain Investment Partners fully exited MINDBODY, Inc. Class A Common Stock in Q4 2018, selling an estimated $16M.
  • Champlain Investment Partners's ten largest holdings make up 19% of its $9.84B portfolio in Q4 2018.
  • Champlain Investment Partners opened 7 new positions and closed 6 in Q4 2018.
  • Champlain Investment Partners's portfolio value fell 13% quarter-over-quarter to $9.84B.

Based on Champlain Investment Partners's 13F filing for Q4 2018, filed 13 Feb 2019.